Practice Advisory: Thrombolytic therapy for acute ischemic stroke - Summary statement

Neurology

Volumn 47, Issue 3, 1996, Pages 835-839

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; STREPTOKINASE;

BRAIN HEMORRHAGE; DRUG USE; FIBRINOLYTIC THERAPY; HUMAN; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0029846911     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.3.835     Document Type: Review

References (6)

1. NINDS rt-PA Stroke Study Group. Tissue Plasminogen Activator for Acute Ischemic Stroke. N Engl J Med 1995;333:1581-1587.
2. del Zoppo, GJ. Acute Stroke - On the Threshold of a Therapy? (editorial). N Engl J Med 1995;333:1632-1633.
3. Adams HP, Brott T, Furlan A, et al. A supplement to the guidelines for the management of patients with acute ischemic stroke: use of thrombolytic drugs. Stroke (in press).
4. Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20:864-870.
5. Leaker M, Nitschmann E, Mitchell L, et al. Thrombolytic therapy in pediatric patients. Thromb Haemost 1995;73:948.
6. Cook, DJ, Guyatt GH, Laupacis A, et al. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1992;102(Suppl 4):3055-3115.